U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Development & Approval Process (Drugs)
  4. Development Resources
  5. Cefotaxime – Injection products
  1. Development & Approval Process (Drugs)

Cefotaxime – Injection products

Cefotaxime – Injection products

Recognized Interpretive Criteria

Exceptions to the recognized standard of CLSI M100

 

Minimum Inhibitory
Concentrations

(mcg/mL)

Disk Diffusion
(zone diameter in mm)

Pathogen

S

I

R

S

I

R

Enterobacteriaceae

M100 standard is recognized

Acinetobacter spp.

≤1

2

≥4

-

-

-

Other Non-Enterobacteriaceae

≤1

2

≥4

-

-

-

Haemophilus influenzae and parainfluenzae

≤1

-

-

-

-

-

Neisseria gonorrhoeae

M100 standard is recognized

Streptococcus pneumoniae
(meningitis)

M100 standard is recognized

-

-

-

Streptococcus pneumoniae
(non-meningitis)

M100 standard is recognized

-

-

-

Streptococcus spp β- Hemolytic Group

M100 standard is recognized

Streptococcus spp Viridans Group

M100 standard is recognized

Neisseria meningitidis

M100 standard is recognized

Anaerobes

≤1

2

≥4

-

-

-

S = Susceptible; I = Intermediate; R = Resistant